Trials / Conditions / Neuroendocrine Tumor of the Lung
Neuroendocrine Tumor of the Lung
4 registered clinical trials studyying Neuroendocrine Tumor of the Lung — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Safety Study of 212Pb-Pentixather Radioligand Therapy NCT05557708 | Yusuf Menda | EARLY_Phase 1 |
| Not Yet Recruiting | A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate NCT06941480 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Recruiting | Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors NCT06472388 | AC Camargo Cancer Center | Phase 2 |
| Active Not Recruiting | A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors NCT06148636 | David Bushnell | EARLY_Phase 1 |